These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 15673797

  • 21. The new drug marketing: a consumer protection perspective.
    Woodward D.
    Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
    [No Abstract] [Full Text] [Related]

  • 22. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Berry MD.
    Issue Brief Health Policy Track Serv; 2012 Dec 31; ():1-79. PubMed ID: 23297449
    [No Abstract] [Full Text] [Related]

  • 23. The regulation of prescription drug advertising.
    Rheinstein RH, Hugstad PS.
    Leg Med Annu; 1978 Dec 31; ():407-19. PubMed ID: 756944
    [No Abstract] [Full Text] [Related]

  • 24. The learned intermediary doctrine: past, present and future.
    Alsobrook HB.
    Leg Med; 1994 Dec 31; ():269-80. PubMed ID: 7830482
    [No Abstract] [Full Text] [Related]

  • 25. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W.
    Food Drug Law J; 1995 Dec 31; 50(4):553-67. PubMed ID: 10343019
    [No Abstract] [Full Text] [Related]

  • 26. Direct-to-consumer advertising--where does the public interest lie?
    Saunders B.
    N Z Med J; 2003 Aug 22; 116(1180):U557; discussion U557. PubMed ID: 14581978
    [No Abstract] [Full Text] [Related]

  • 27. Direct-to-Consumer advertising for prescription drugs.
    Schommer JC.
    Minn Med; 2005 Mar 22; 88(3):32-3, 45. PubMed ID: 15852593
    [No Abstract] [Full Text] [Related]

  • 28. The federal regulation of prescription drug advertising and promotion.
    Kessler DA, Pines WL.
    JAMA; 1990 Nov 14; 264(18):2409-15. PubMed ID: 2231998
    [Abstract] [Full Text] [Related]

  • 29. Regulation of prescription drug promotion: direct-to-consumer advertising.
    Baylor-Henry M, Drezin NA.
    Clin Ther; 1998 Nov 14; 20 Suppl C():C86-95. PubMed ID: 9915094
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan 14; 71(1):34-9. PubMed ID: 16491527
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Major issues in marketing regulation.
    Pines WL.
    Food Drug Law J; 1997 Jan 14; 52(3):297-302. PubMed ID: 10343028
    [No Abstract] [Full Text] [Related]

  • 35. Direct-to-consumer advertising of prescription drugs.
    Frosch DL, Grande D.
    LDI Issue Brief; 2010 Jan 14; 15(3):1-4. PubMed ID: 20469541
    [Abstract] [Full Text] [Related]

  • 36. A history of adverse drug experiences: Congress had ample evidence to support restrictions on the promotion of prescription drugs.
    Waxman HA.
    Food Drug Law J; 2003 Jan 14; 58(3):299-312. PubMed ID: 14626231
    [No Abstract] [Full Text] [Related]

  • 37. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW, Bang HK.
    Health Mark Q; 2000 Jan 14; 17(3):39-56. PubMed ID: 11010219
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Over-the-counter sales of statins and other drugs for asymptomatic conditions.
    Tinetti ME.
    N Engl J Med; 2008 Jun 19; 358(25):2728-32. PubMed ID: 18565867
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.